BlackRock Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$56.9M Buy
521,832
+11,773
+2% +$1.28M 0.03% 569
2016
Q3
$62M Sell
510,059
-7,852
-2% -$954K 0.03% 537
2016
Q2
$73.2M Sell
517,911
-8,454
-2% -$1.19M 0.04% 489
2016
Q1
$68.7M Buy
526,365
+15,324
+3% +$2M 0.04% 492
2015
Q4
$71.8M Buy
511,041
+95,753
+23% +$13.5M 0.04% 475
2015
Q3
$55.2M Buy
415,288
+19,180
+5% +$2.55M 0.03% 531
2015
Q2
$69.7M Buy
+396,108
New +$69.7M 0.04% 490
2015
Q1
Sell
-337,458
Closed -$55.3M 2857
2014
Q4
$55.3M Buy
337,458
+175,527
+108% +$28.7M 0.03% 559
2014
Q3
$26M Buy
161,931
+131,629
+434% +$21.1M 0.02% 719
2014
Q2
$4.46M Sell
30,302
-14,483
-32% -$2.13M ﹤0.01% 1133
2014
Q1
$6.21M Buy
44,785
+11,458
+34% +$1.59M ﹤0.01% 1034
2013
Q4
$4.22M Buy
33,327
+4,962
+17% +$628K ﹤0.01% 1114
2013
Q3
$2.61M Buy
28,365
+4,621
+19% +$425K ﹤0.01% 1315
2013
Q2
$1.63M Buy
+23,744
New +$1.63M ﹤0.01% 1385